Related Experiment Videos

Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3

Claire Magnon1, Ariane Galaup, Brian Mullan

  • 1UMR 8121 Laboratoire de vectorologie et transfert de gènes, Institut Gustave Roussy, Villejuif cedex, France. magnon@igr.fr

Cancer Research
|May 19, 2005
PubMed

Insights

Canstatin, a collagen-derived inhibitor, triggers mitochondrial apoptosis in tumor and endothelial cells via integrin receptor cross-talk, explaining its potent anticancer effects.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Canstatin is a collagen-derived peptide with demonstrated antitumor properties.
  • Understanding its mechanism of action, including target receptors and signaling pathways, is crucial for therapeutic development.

Purpose of the Study:

  • To elucidate the functional receptors and intracellular signaling pathways activated by canstatin.
  • To explain the potent in vivo antitumor efficacy of canstatin.

Main Methods:

  • Generation of a canstatin-human serum albumin (CanHSA) fusion protein for expression.
  • Investigating the apoptotic mechanisms induced by CanHSA in endothelial and tumor cells.
  • Comparing CanHSA's effects with angiostatin kringle domains (K1-3) fused with HSA.

Main Results:

  • CanHSA induces mitochondrial apoptosis via procaspase-9 cleavage in both endothelial and tumor cells.
  • This effect is mediated by cross-talk between alphavbeta3- and alphavbeta5-integrin receptors.
  • Angiostatin K1-3, in contrast, acts only on endothelial cells via alphavbeta3-integrin and caspase-8, without mitochondrial damage.

Conclusions:

  • Canstatin's potent anticancer activity is linked to its ability to induce mitochondrial apoptosis through specific integrin receptor cross-talk.
  • These findings provide critical insights into canstatin's therapeutic potential in cancer treatment.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...